Claudia Berger

Claudia Berger has extensive experience in clinical development and clinical trial operations. Claudia currently holds the position of Senior Vice President Clinical Development at ImmunOs Therapeutics AG since October 2021. Prior to this, they served as the Chief Clinical Development Officer at Kinarus AG from April 2021. Claudia previously worked at Inflzome Ltd as the Director of Clinical Operations from January 2020 to September 2021. Before that, Claudia held positions at Kinarus AG & Strekin AG as the Director and Head of Clinical Trial Operations from August 2015 to March 2020. Claudia also worked at Delenex Therapeutics AG as the Director and Head of Clinical Trial Operations from March 2012 to December 2015. Claudia started their career at Novartis NIBR as a Clinical Principal Scientist from 2011 to 2012. Prior to that, they worked at Novartis Institute for Biomedical Research (NIBR) as a Clinical Trial Leader III and CTL III from 2007 to 2012. Claudia began their career at PFC Pharma Focus as a Lead CRA / Project Manager from 2002 to 2007.

Claudia Berger completed their education at the University of Basel. From 1995 to 2000, they pursued a Master's degree in Pharmacy. Later, in 2003 to 2005, Claudia attended the ECPM Course at the same university. However, no specific degree or field of study was mentioned for this course.